awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53786874-837A3FB4-5985-43C1-B567-A1B206811834
Q53786874-837A3FB4-5985-43C1-B567-A1B206811834
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-837A3FB4-5985-43C1-B567-A1B206811834
Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer.
P2860
Q53786874-837A3FB4-5985-43C1-B567-A1B206811834
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-837A3FB4-5985-43C1-B567-A1B206811834
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ecdb0433a18e89e9d2969dae90443410f832abbd
P2860
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.